In Vitro Antibody Activity Test

0
739

Two important mechanisms used by antibody to kill targeted cells are Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), and Complement Dependent Cytotoxicity (CDC). Reliable and high quality ADCC & CDC assays have assumed greater significance with the growing importance in medicine of bio-engineering antibodies and their role in combating cancers. By implementing strict QC standards, Creative Diagnostics can perform high quality assays for ADCC/CDC.

CDC is the mechanism by which antibodies lyse unwanted targets by triggering a series complement-related reactions. The CDC assay is used as a safety profiling measure by screening  candidate(s) to ensure the compound doesn't induce complement events and to look for other unexpected effects. Fresh blood that is less than four hours old is used in this assay as there are better responses/results utilizing fresher blood.

Site içinde arama yapın
Kategoriler
Read More
Networking
Middle East and Africa Flat Glass Market Research Report: Growth, Share, Value, Size, and Analysis By 2030
Executive Summary Middle East and Africa Flat Glass Market Size and Share Forecast Data...
By Travis Rohrer 2025-10-29 08:21:29 0 3K
Other
United States Antimicrobial Additives Market Analysis: Key Growth Drivers, Polymer Protection, and Forecast
In the United States, strong demand driven by stringent FDA and EPA regulatory guidelines,...
By Mayra Luee 2026-10-28 12:14:20 0 104
Other
Global Dercum’s Disease Treatment Market Size, Trends And Analysis 2032
  According to the latest report published by Data Bridge Market...
By Trushali Ramteke 2026-06-10 03:47:46 0 902
Oyunlar
22 Bishopsgate: Gordon Ramsay's Ambitious New Project
London's second-tallest skyscraper, 22 Bishopsgate, will soon house Gordon Ramsay's most...
By Xtameem Xtameem 2025-11-01 01:44:55 0 3K
Other
3D Printing Ceramics Market: Advanced Manufacturing Trends and Applications
According to the latest report published by Data Bridge Market Research, the 3D...
By Dbmr Market 2026-06-03 11:44:52 0 1K